Financials (USD)
Sales 2024 * | 120M | Sales 2025 * | 130M | Capitalization | 91.32M |
---|---|---|---|---|---|
Net income 2024 * | -16M | Net income 2025 * | 1M | EV / Sales 2024 * | 0.76 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.7 x |
P/E ratio 2024 * |
-5.65
x | P/E ratio 2025 * |
192
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.77% |
Latest transcript on Depomed Inc
Managers | Title | Age | Since |
---|---|---|---|
Heather Mason
CEO | Chief Executive Officer | 63 | 19-01-31 |
Ajay Patel
DFI | Director of Finance/CFO | 40 | 19-06-30 |
Howard Franklin
CTO | Chief Tech/Sci/R&D Officer | - | 23-03-05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Staple
CHM | Chairman | 72 | 03-10-31 |
James Tyree
BRD | Director/Board Member | 71 | 16-09-30 |
William McKee
BRD | Director/Board Member | 62 | 17-02-28 |
1st Jan change | Capi. | |
---|---|---|
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |